In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A

Steroids

Volumn 50, Issue 1-3, 1987, Pages 147-161

  Steele, Ronald E ^a   Mellor, Lynn B ^a   Sawyer, Wilbur K ^a   Wasvary, Jong M ^a   Browne, Leslie J ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN; FADROZOLE; RADIOISOTOPE; TESTOSTERONE;

ADRENAL HYPERTROPHY; ANIMAL CELL; ANIMAL EXPERIMENT; FEMALE; HUMAN; IN VITRO STUDY; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OVARY; PLACENTA; RAT; UTERUS ATROPHY;

ANDROGENS; ANIMAL; AROMATASE; CORTICOSTERONE; ESTROGEN ANTAGONISTS; FADROZOLE; FEMALE; HUMAN; IMIDAZOLES; MICROSOMES; NITRILES; ORGAN WEIGHT; OVARY; PLACENTA; PREGNANCY; RATS; RATS, INBRED STRAINS;

EID: 0023517368     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(83)90068-5     Document Type: Article

References (24)

1. The involvement of human placental microsomal cytochrome P-450 in aromatization
2. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide
3. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer
4. Treatment of metastatic breast cancer with aminoglutethimide
5. Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer
6. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma
7. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma
8. Inhibition of adrenal cortisosteroid synthesis by aminoglutethimide: studies of the mechanism of action
9. Modifications of enzymatic activity and difference spectra of cytochrome P-450 from various sources by cholesterol side-chain cleavage inhibitors
10. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione
11. Enzymological studies of rat luteinized ovaries in relation to acute reduction of aromatizable androgen formation and stimulated production of progestins
12. Nycthemeral rhythm in adrenal responsiveness to ACTH.
13. Protein measurement with Folin phenol reagent
14. An alternative method for the study of follicle-stimulating hormone effects on aromatase activity in Sertoli cell cultures
15. New tables for multiple comparisons with a control
16. Kinetic properties of human placental aromatase
17. Evidence of the direct aromatization of testosterone and different aromatization sites for testosterone and androstenedione in human placental microsomes
18. Substrate specificity of the placental microsomal aromatase
19. Aromatization of androstenedione, 19-hydroxy-androstenedione, and 19-oxo-androstenedione at a common catalytic site in human placental microsomes
20. High-affinity steroid binding to rat testis 17α-hydroxylase and human placental aromatase
21. Studies on the mechanism of estrogen biosynthesis in the rat ovary-I
22. In vitro and in vivo aromatase inhibition by aminoglutethimide
23. Mechanism of estrogen biosynthesis
24. Postovulatory decrease in estrogen production is caused by the diminished supply of aromatizable androgen to ovarian aromatase